Thanks glotch, your mum appears to be in the target range ... which is good.The future looks bright for BioA and at a much cheaper price than Ropren can have a much bigger reach.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game